Advancing Connected Health Solutions

Estimated Long-Term Growth Rates Our solutions play an important role in managing these chronic diseases in home Healthcare and Lost Chronic Disease Productivity Costs ($bn) AdaptHealth Product Product Line PF 2019 Net Revenue less BD Estimated Long-Term Growth Rates (in $bn) (in $mm) CGM, Insulin Diabetes $327 Respiratory $128 3.0-5.0% Pumps, Test Strips Heart Disease & $322 Oxygen, Supplies Stroke | Sleep 340 7.0-9.0% Obstructive Sleep $150 СРАР, ВІРАР HME 111 2.0-4.0% Apnea Obesity $147 PAP, Mobility, Supplies Diabetes 189 10.0-12.0% COPD $49 Oxygen, NIV Other Supply 248 2.0 - 4.0% Total $1,016 5.0 - 7.0% Adapt distributes products and provides services to patients with high-cost, chronic diseases Source: American Diabetes Association, CDC, American Association of Sleep Medicine ++ adapthealth Assuming 1-2% share capture, potential to grow at 7-10% organically 12

View entire presentation